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Introduction
The heavy burden and public awareness of HIV/AIDS, 
tuberculosis, and malaria in sub-Saharan Africa should 
not obscure recognition of the substantial health 
transition that is underway, and the implications of this 
transition for the delivery of eﬀ ective primary health care. 
Moreover, as availability and coverage of highly active 
antiretroviral therapy (HAART) extends and takes eﬀ ect, 
with ensuing improvements in life expectancy, the 
constraint exerted on cardiovascular and other chronic 
non-communicable diseases will be loosened, leading to 
a probable upswing in mortality, morbidity, and risk 
related to such diseases. 
Primary health-care systems have mainly evolved in a 
pre-transitional era and have adapted little to the growing 
demand for continuous, long-term care. However, to 
respond eﬀ ectively to personal and community needs, 
and to enhance the eﬀ ect of services, primary health-care 
systems should develop an approach to the management 
of chronic diseases. The imperative of HIV/AIDS, and 
particularly the urgent need to deliver HAART, is driving 
the development of health systems in large parts of 
sub-Saharan Africa. Therefore the opportunity exists to 
harness this eﬀ ort and ensure that it is applied to 
management of both chronic infectious and non-
communicable diseases. Up until now, however, public-
sector systems supporting primary health care have not 
been regarded as the approach of choice for management 
of HIV/AIDS and related illness. Instead, funders and 
programme leaders have opted to establish new, dedicated 
programmes rather than invest in strengthening the 
existing comprehensive but generally weak delivery 
platforms that are common to the public-health sector.
Inﬂ uenced by the ideals of the Alma-Ata Declaration,1 
the new South African Government in 1994 articulated a 
policy of district health development that centred on 
primary health care. This idea remains national policy, 
with President Mbeki using his State of the Nation 
address to emphasise “accelerating our advance towards 
the achievement of the goal of health for all”.2 Although 
the envisaged health gains have not materialised,3 the 
country could yet turn a corner.
With comprehensive cause-speciﬁ c mortality data 
from a border region of rural southern Africa from 1992 
to 2005, supplemented by available morbidity and risk 
data, we aimed to investigate the extent and nature of the 
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health transition that is underway and to consider the 
implications for primary health care.
Methods
Study setting and population
The Agincourt subdistrict includes about 70 000 people 
in 11 500 households and 21 villages. It covers 402 km² in 
rural northeast South Africa, adjacent to its border with 
Mozambique. The Agincourt population has been under 
continuous health and sociodemographic surveillance by 
the MRC/Wits Rural Public Health and Health Transitions 
Research Unit since 1992. This surveillance preceded the 
advent of democracy, was introduced to inform policy 
about decentralised health systems development, covers 
the ﬁ rst decade of profound sociopolitical change, and 
documents the accelerating eﬀ ect of the HIV/AIDS 
epidemic. Migration after the Mozambican civil war led 
to immigrants comprising almost a third of the 
population.
Similar to much of rural southern Africa, the Agincourt 
subdistrict is a labour-sending area, with most adults 
seeking work in industrial, mining, or agricultural 
centres elsewhere, and oﬀ ers limited local employment 
and farming opportunity. Household income comes 
from migrant remittances and employment in the 
public sector, and through tourism. In South Africa, 
social transfers (pensions and child-support grants) 
have a crucial role in redistribution of income to poor 
households. Migrant labour is a constant feature, 
involving some 60% of men aged 30–54 years and a 
quarter of women aged 25–49 years.4 The area has poor 
infrastructure despite improvement to electricity and 
water supply. Health facilities include a health centre 
with ﬁ ve satellite clinics and three district hospitals that 
are 25–60 km away from Agincourt. 
Demographic transition has been shown by a sustained 
decrease in fertility since the mid-1970s which, most 
unusually, has stabilised at near replacement level with 
little recent change in population size.5 Decreases in 
mortality were sustained until the mid-1990s when the 
HIV/AIDS epidemic took oﬀ , inducing a major reversal 
in mortality in young adults and children younger than 
5 years.6 By 2005, life expectancy at birth had fallen by 
12 years for women and by 14 years for men.7
Data collection
Health and sociodemographic surveillance included 
registration of the entire subdistrict population through 
a baseline census in 1992, and subsequent prospective 
follow-up through yearly updates that systematically 
recorded basic demographic events (births, deaths, and 
migrations).8 Household interviews were undertaken by 
experienced ﬁ eldworkers who interviewed the most 
knowledgeable adult available, veriﬁ ed existing data, and 
carefully recorded new events. Data were entered onsite, 
had many validity checks, and were stored and 
manipulated in a secure relational database. Quality 
assurance included ﬁ eld and data checks to ensure robust 
numerator and denominator data for the calculation of 
rates. 
For every death, a probable cause was established 
through a verbal autopsy that was undertaken by lay 
ﬁ eldworkers.8 The ﬁ eldworker gathered information 
from a close caregiver about signs and symptoms of the 
terminal illness, lifestyle behaviours, and treatment 
sought. Cause of death was established through physician 
assessment of the verbal autopsy, and all diagnoses were 
coded according to the International Classiﬁ cation of 
Diseases (ICD-10). When two physicians working 
independently reached the same diagnosis, this was 
accepted as the probable cause of death. When their 
assessments diﬀ ered and agreement could not be 
reached, a third physician arbitrated to achieve consensus. 
This method was validated in Agincourt in the mid-1990s.9 
After revalidation to assess the validity of HIV/AIDS 
diagnoses, HIV/AIDS and tuberculosis were combined, 
resulting in sensitivity and speciﬁ city approaching 80% 
for the one category. HIV/AIDS and tuberculosis share 
similar signs and symptoms, resulting in misclassiﬁ cation 
when attempting to distinguish the two on verbal autopsy. 
Both diseases commonly co-exist, especially in younger 
adults, justifying their combination into one HIV and 
tuberculosis category.
With expert guidance from physician-researchers 
experienced in the clinical management of children and 
adults, we classiﬁ ed every death as requiring either acute 
or chronic care. Acute disorders were deﬁ ned as 
potentially curable with up to 1 month of appropriate 
treatment, and chronic disorders as either incurable or 
requiring more than 1 month of treatment. We assigned 
an undetermined cause of death to a category of unknown 
care.
All surveillance-based studies were reviewed and 
approved by the Committee for Research on Human 
Subjects (Medical) of the University of the Witwatersrand, 
Johannesburg, South Africa (protocol M960720). 
Informed consent was obtained at individual and 
household level at every follow-up visit, whereas 
community consent from civic and traditional leadership 
was secured at the start of surveillance and reaﬃ  rmed 
from time to time.
Statistical analysis
We calculated period (1992–94, 1995–97, 1998–2001, and 
2002–05), sex-speciﬁ c, age-speciﬁ c, all-cause, and 
cause-speciﬁ c mortality rates by dividing deaths by 
person-years exposed within each category. Mortality 
rates by health-care category (acute or chronic) were 
calculated in the same way. We calculated age-standardised 
crude death rates using the standard age structure from 
the International Network for the Demographic 
Evaluation of Populations and Their Health (INDEPTH), 
which is a standard appropriate for sub-Saharan Africa.10 
The top ﬁ ve causes of death by period and age were 
For more about the 
International Network for the 
Demographic Evaluation of 
Populations and Their Health 
(INDEPTH) see http://www.
indepth-network.org
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identiﬁ ed as percentages of total deaths within each 
category. We used Microsoft SQL Server 2005 for data 
management and extraction, and did all analyses with 
Stata (Intercooled version 9.0 and SE 10.0) and Microsoft 
Excel.
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for pub-
lication.
Results
Table 1 presents age-standardised death rates for four 
periods from 1992 to 2005, showing that mortality rates 
have increased substantially since the mid-1990s. All rate 
ratios indicate change in the most recent period (2002–05) 
relative to the base period (1992–94). All-cause mortality 
increased by 87% over the whole period, largely because 
of a six-fold rise in infectious and parasitic disease and a 
modest increase in non-communicable disease (table 1). 
The increase in infectious and parasitic disease mortality 
was signiﬁ cant in all age and sex groups apart from 
children aged 5–14 years (for whom the change in HIV 
and tuberculosis mortality was signiﬁ cant; p=0·012) and 
adults 65 years and older (data not shown). The increase 
in mortality from non-communicable disease was 
signiﬁ cant for males (rate ratio 1·32 [95% CI 1·08–1·60]; 
p=0·006) but showed little change for females (1·02 
[0·82–1·60]; p=0·85). Age-speciﬁ c mortality from 
non-communicable disease increased signiﬁ cantly in 
adults who were 30 years and older (1·22 [1·02–1·46]; 
p=0·026);  the change in younger age-groups was not 
signiﬁ cant. By contrast, external causes remained 
constant at a fairly high level of mortality (table 1). 
Undetermined causes increased signiﬁ cantly, partly 
because of the emergence of HIV/AIDS which can be 
diﬃ  cult to assess by verbal autopsy.
With respect to increased infectious and parasitic 
disease mortality, the change was driven by HIV and 
tuberculosis (rate ratio 10·75 [7·89–14·63]; p<0·0001), 
with the change in female risk of death (15·06 
[8·88–27·76]; p<0·0001) almost double the change in 
male risk (8·13 [5·55–12·36]; p<0·0001). Other infectious 
diseases that signiﬁ cantly increased mortality rates 
included acute respiratory infections, which were 
probably aﬀ ected by co-morbidity with HIV/AIDS, and 
malaria, which was possibly aﬀ ected by inadequate 
control measures in neighbouring countries.11 With 
respect to non-communicable disease, change was less 
evident because of the overwhelming eﬀ ect of HIV and 
tuberculosis. Age-standardised rates for deaths due to 
diabetes increased signiﬁ cantly, although numbers were 
small (2·57 [1·20–6·32]; p=0·008); this ﬁ nding was also 
true for the conditions grouped into the category termed 
other non-communicable diseases (1·50 [1·01–2·28]; 
p=0·038). In adults aged 65 years and older, deaths due 
to vascular disease (stroke, ischaemic heart disease, and 
hypertensive diseases) increased by 65% (1·65 
[0·99–2·76]; p=0·056) and deaths due to malignant 
neoplasms (excluding female genital malignancies) more 
than doubled (2·20 [1·04–4·66]; p=0·040). 
Table 2 ranks the ﬁ ve most common causes of death 
from 1992 to 2005. The early 1990s were characterised by 
diseases of poverty in children (acute diarrhoea and 
malnutrition made up nearly 40% of deaths), accidents 
and violence in those aged 15–49 years, and 
non-communicable disease in middle-aged and older 
adults (aged ≥50 years). The mid-1990s was the turning 
point: over the ensuing decade, mortality from HIV and 
tuberculosis increased from little over 10% to a third of 
all deaths in children younger than 5 years; from a ﬁ fth 
to almost half of deaths in those aged 15–49 years; and 
from a sixth to more than a quarter of deaths in people 
aged 50–64 years (table 2). In people aged 15–49 years, 
violent and accidental deaths were displaced by HIV and 
tuberculosis as the top ranking cause by the mid-1990s, 
but remained in second and third place over the 
remaining years (table 2). In women aged 15–49 years, 
obstetric deaths ranked ﬁ rst in the early period but not 
subsequently (data not shown). In adults aged 
50–64 years, non-communicable disease took the top ﬁ ve 
places in the early 1990s, with vascular disease ranked 
ﬁ rst. By the mid-1990s, HIV and tuberculosis were 
ranked ﬁ rst, followed by vascular and other cardiac 
disorders (table 2). Non-communicable disease and 
tuberculosis dominated in the oldest age group 
throughout, with vascular disease constituting the largest 
proportion of deaths from the mid-1990s; by the late 
Years Relative change
1992–94 1995–97 1998–2001 2002–05 RR (95% CI) p value
Broad cause categories
All causes 593 604 737 1111 1·87 (1·73–2·03) <0·0001
Infectious and parasitic 
diseases
74 147 255 446 5·98 (4·85–7·38) <0·0001
Non-communicable diseases 197 158 187 227 1·15 (0·99–1·33) 0·066
External causes* 76 63 61 72 0·95 (0·74–1·21) 0·673
Ill deﬁ ned or unknown 198 178 115 237 1·19 (1·03–1·38) 0·019
Broad health-care categories
All health care 593 604 737 1111 1·87 (1·73–2·03) <0·0001
Acute care† 162 148 192 212 1·31 (1·12–1·55) 0·0003
Chronic care‡ 209 230 330 550 2·63 (2·30–3·01) <0·0001
Ill deﬁ ned/unknown care§ 222 225 215 348 1·57 (1·37–1·80) <0·0001
All rates are per 100 000 person years (N=6153). RR=rate ratio. All rate ratios indicate change in last time period 
(2002–05) relative to ﬁ rst period (1992–94). *External causes include homicide, suicide, road traﬃ  c accidents, 
accidental injuries. †Acute care: for disorders that are potentially curable with up to 1 month of appropriate treatment. 
‡Chronic care: for disorders that are incurable or need more than 1 month of appropriate treatment. §Diﬃ  cult to 
classify as acute or chronic care.
Table 1: Age-standardised death rates for broad cause categories and broad health-care categories in 
Agincourt subdistrict, 1992–2005
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1990s, non-communicable diseases had displaced 
tuberculosis from third to fourth place (table 2). Although 
numbers are small in the 5–14 year age-group, accidents 
remained most common overall, although we noted a 
growing number of deaths from HIV and tuberculosis 
(table 2).
We also classiﬁ ed diseases according to the type of 
patient care that they required (acute or chronic). Mortality 
rates in each care category increased over time, indicating 
an overall increasing care burden on the health system 
(table 1 and the ﬁ gure). Notably, the burden of disorders 
requiring chronic care increased dis proportionately relative 
to the burden requiring acute care (table 1 and the ﬁ gure).
Discussion
Changes in mortality patterns provide insight into the 
evolving course of health transition in South Africa. In 
all but the oldest age group, HIV and tuberculosis has 
had an overwhelming eﬀ ect, supressing deaths due to 
acute infection and malnutrition in children, injury in 
people aged 15–49 years, and non-communicable disease 
in adults aged 50–64 years. However, non-communicable 
diseases had already emerged as prominent causes of 
death in middle-aged adults during the pre-HIV era 
(table 2). Despite the rise in mortality due to HIV and 
tuberculosis, and related infectious disease, mortality 
from non-communicable disease remains evident, 
1992–94 1995–97 1998–2001 2002–05
0–4 years of age
Total 158 140 336 417
1 Diarrhoea 31 (20%) Diarrhoea 33 (24%) HIV/tuberculosis 73 (22%) HIV/tuberculosis 141 (34%)
2 Malnutrition 28 (18%) HIV/tuberculosis 16 (11%) Diarrhoea 39 (12%) Diarrhoea 43 (10%)
3 Perinatal disorders 12 (8%) Acute respiratory infection 11 (8%) Acute respiratory infection 34 (10%) Acute respiratory infection 32 (8%)
4 Accidental injuries 9 (6%) Malnutrition 9 (6%) Perinatal disorders 30 (9%) Malnutrition 32 (8%)
5 Other infectious and parasitic diseases 8 (5%) Accidental injuries 6 (4%) Malnutrition 26 (8%) Perinatal disorders 23 (6%)
5–14 years of age
Total 28 37 50 75
1 Other NCDs* 7 (25%) Malaria 4 (11%) Accidental injuries 12 (24%) Accidental injuries 11 (15%)
2 Road traﬃ  c accidents 4 (14%) Other NCDs* 3 (8%) Malaria 6 (12%) HIV/tuberculosis 11 (15%)
3 Epilepsy 3 (11%) Accidental injuries 3 (8%) HIV/tuberculosis 5 (10%) Road traﬃ  c accidents 9 (12%)
4 Congenital 3 (11%) HIV/tuberculosis 3 (8%) Suicide 5 (10%) Other NCDs* 5 (7%)
5 Accidental injuries 3 (11%) Road traﬃ  c accidents 2 (5%) Road traﬃ  c accidents 3 (6%) Other infectious and parasitic 4 (5%)
15–49 years of age
Total 159 251 609 1352
1 Assault 27 (17%) HIV/tuberculosis 53 (21%) HIV/tuberculosis 252 (41%) HIV/tuberculosis 651 (48%)
2 Road traﬃ  c accident 14 (9%) Assault 25 (10%) Assault 32 (5%) Assault 37 (3%)
3 HIV/tuberculosis 13 (8%) Road traﬃ  c accident 22 (9%) Road traﬃ  c accident 32 (5%) Road traﬃ  c accident 35 (3%)
4 Other cardiac disorders† 10 (6%) Other NCDs* 12 (5%) Other NCDs* 28 (5%) Malaria 29 (2%)
5 Neoplasms‡ 9 (6%) Neoplasms‡ 11 (4%) Malaria 24 (4%) Other NCDs* 27 (2%)
50–64 years of age
Total 105 154 217 453
1 Vascular disease§ 20 (19%) HIV/tuberculosis 24 (16%) HIV/tuberculosis 38 (18%) HIV/tuberculosis 126 (28%)
2 Chronic liver disease¶ 8 (8%) Vascular disease§ 10 (6%) Vascular disease§ 26 (12%) Vascular disease§ 31 (7%)
3 Other cardiac disorders† 7 (7%) Other cardiac disorders† 10 (6%) Other NCDs* 10 (5%) Other cardiac disorders† 31 (7%)
4 Other NCDs* 7 (7%) Other NCDs* 10 (6%) Neoplasms‡ 10 (5%) Other NCDs* 26 (6%)
5 Neoplasms‡ 6 (6%) Assault 9 (6%) Female genital neoplasms 10 (5%) Neoplasms‡ 22 (5%)
≥65 years of age
Total 193 355 479 578
1 Other cardiac disorders† 30 (16%) Vascular disease§ 39 (11%) Vascular disease§ 62 (13%) Vascular disease§ 76 (13%)
2 Vascular disease§ 18 (9%) Other cardiac disorders† 33 (9%) Neoplasms‡ 49 (10%) Other cardiac disorders† 58 (10%)
3 Tuberculosis|| 15 (8%) Tuberculosis|| 24 (7%) Other cardiac disorders† 38 (8%) Neoplasms‡ 54 (9%)
4 Neoplasms‡ 8 (4%) Neoplasms‡ 20 (6%) Tuberculosis|| 31 (6%) Tuberculosis|| 28 (5%)
5 Chronic liver disease¶ 5 (3%) Diarrhoea 18 (5%) Other NCDs* 29 (6%) Other NCDs* 26 (4%)
NCD=non-communicable diseases. *Includes disorders omitted from other categories such as anaemia, dementia, chronic obstructive pulmonary disease, asthma, peptic ulcer disease, etc. †All circulatory system 
diseases excluding hypertensive disease, ischaemic heart disease, and cerebrovascular disease. ‡All malignant neoplasms excluding those of female genital organs. §Cerebrovascular disease, ischaemic heart 
disease, and hypertensive disease. ¶Excludes all infectious causes. ||The combined HIV/tuberculosis category was not used in the oldest age group because of the virtual absence of HIV/AIDS deaths. 
Table 2: Five most common causes of death by age and time period in Agincourt subdistrict, 1992–2005
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particularly in males for whom the relative increase in 
HIV and tuberculosis mortality, although substantial, 
was much less than that for females. Signiﬁ cantly rising 
mortality is not limited to younger age groups, but is 
pronounced in adults aged 40–59 years and even older.12 
Thus, were it not for HIV and tuberculosis, we suggest 
that mortality from non-communicable disease would 
be higher.
Because census updates occur only once a year in the 
Agincourt subdistrict, a small number of events might 
have been missed—eg, when a death occurs soon after 
birth and then both are not reported by the household 
respondent. This limitation could result in slightly 
lowered estimates of infant mortality, although the 
problem aﬀ ects a very small proportion of births and 
would not aﬀ ect our ﬁ ndings or conclusions.
Complementary research in Agincourt has focused on 
stroke morbidity and cardiovascular risk. Thorogood and 
colleagues’ ﬁ ndings in 2003 from the Agincourt subdistrict 
showed substantial prevalence of hypertension in men 
and women (more than a quarter of adults aged 35–49 years 
and more than two-ﬁ fths of all adults 35 years and older); 
pronounced obesity in women (mean body-mass index of 
27·2 kg/m² in women 35 years and older); more frequent 
cigarette smoking in men than in women; and modest 
cholesterol and high HDL-cholesterol concentrations 
compared with typical high-income populations 
(webtable).13 This risk factor proﬁ le is reﬂ ected in vascular 
disease morbidity. The prevalence of stroke in Agincourt 
in 2001 was about half that typically recorded in 
high-income regions of the world, with an age-standardised 
prevalence of 290 (95% CI 238–343) per 100 000 people 
aged 15 years and older, but double that noted elsewhere 
in Africa.14 Stroke prevalence increased with age, as it did 
elsewhere. Age-speciﬁ c prevalence was similar in adults 
aged 45–54 years (598 per 100 000) to that recorded in 
New Zealand (615 per 100 000), but was lower in other age 
groups.14,15 These data accord with an anticipated increase 
in vascular non-communicable disease in younger age 
groups during transition. Despite fairly favourable 
cholesterol concentrations, there is evidence of subclinical 
peripheral atheroma in the study population, and adults 
35 years and older had a distribution of the ankle brachial 
index which was similar to that noted in high-income 
populations with peripheral vascular disease.16 Although 
sub-Saharan Africa is usually cited as a region in the 
earliest stage of epidemiological transition,17 this risk and 
morbidity proﬁ le suggests a population in a later stage of 
transition, one that is typically dominated by 
hypertension-related disease. Moreover, there is potential 
for the rural Agincourt population to advance yet further 
to a stage which is typiﬁ ed by the emergence of ischaemic 
heart disease, as has already occurred in people from 
urban South Africa.18 
Agincourt is one of 37 sites in the developing world that 
make up the INDEPTH network and undertake 
prospective monitoring of populations living in deﬁ ned 
geographic areas. A comparison of mortality proﬁ les from 
surveillance sites during 1999–2003 showed that 
malaria-related mortality was highest in west African 
sites, with AIDS-related mortality highest in South Africa. 
Nevertheless, all regions showed emerging cardiovascular 
mortality, with malignant neoplasms, diabetes, and 
digestive disorders also being important.19 Findings from 
sites in urban settings such as Dar-es-Salaam (Tanzania),20 
Nairobi (Kenya), and Bissau (Guinea-Bissau) reinforce 
this emerging trend (unpublished data).
Growing evidence draws attention to the prevalence of 
hypertension in rural and urban locales across the 
continent.21–23 This ﬁ nding aﬃ  rms the conclusion that 
rising blood pressure levels, increasing stroke prevalence 
and associated mortality,20,24,25 and emerging ischaemic 
heart disease26 are indicators of African communities 
that are already advancing through early stages of 
cardiovascular transition.27
Projections forecast that in sub-Saharan Africa, despite 
the excess mortality due to AIDS, the number of people 
aged 60 years and older will double from 34 million in 
2005 to more than 67 million in 2030—a rate of growth 
which is greater than that in industrialised countries.28 
Older adults contend with an extremely stressful reality: 
high morbidity and mortality from HIV/AIDS leaves 
them responsible for the care of their own sick children 
and for the wellbeing of their grandchildren. They 
themselves, however, are at risk not only for HIV/AIDS 
but also for stroke, diabetes, hypertension, and related 
chronic disorders (table 2). The health transition is thus 
directly and indirectly aﬀ ecting three generations, with 
the oldest of these, who have an irreplaceable social role, 
clearly vulnerable to chronic non-communicable 
diseases.
For local health systems development, national and 
especially subnational data are essential. The Agincourt 
data series conveys robust information that is well suited 
to consideration of the challenges facing primary 
health-care systems. Evidence suggests that, in the same 
community and to a substantial degree, chronic infectious 
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illness and chronic non-communicable disease coexist; 
moreover, that the explosive progression of HIV/AIDS 
mortality has slowed an already advancing transition in 
non-communicable disease. However, scaled-up eﬀ orts 
at HAART delivery, and the resulting population eﬀ ect, 
can be expected to decrease adult mortality and raise life 
expectancy.29 Thus, levels of non-communicable disease 
and risk should rebound in parallel with growing 
numbers of people who are receiving long-term 
antiretroviral therapy. Already, however, prevailing 
mortality patterns—documented in Tanzania at an earlier 
stage of transition30,31—suggest an escalating need for 
chronic-care services that cut across conventional 
categories of infectious and non-communicable disease.
Public-health leadership is thus at a crossroads. Failure 
to grasp the changes underway and adjust the prevailing 
model of care—which was born in a pre-transitional era 
and focused on acute, episodic infectious disease 
management31,32—will probably lead to a deteriorating 
relation between community needs and services provided. 
And it will be accompanied by progressively demotivated 
staﬀ , loss of conﬁ dence by users, and little eﬀ ect on 
population health. The problem is shown by consideration 
of chronic-disease management in Agincourt (panel).
Placement of integrated chronic care at the centre of 
primary health-care systems will ensure a comprehensive 
response to one of the most important health problems 
confronting local communities. In view of overriding 
concern with HIV/AIDS in sub-Saharan Africa, major 
impetus for chronic systems development should derive 
from eﬀ orts to accelerate the delivery of HAART, 
particularly through decentralising delivery to local level. 
Further, integration of HAART (and the full package of 
chronic infectious disease management) within general 
chronic care could well reduce stigma and enhance 
access and use.36 But it will need a diﬀ erent outlook from 
service leadership and their funders—ie, one that 
recognises the fundamental compatibility between 
enhanced HIV/AIDS management and the strengthening 
of health systems. If scaled-up delivery of HAART can 
provide the means and opportunity to re-engineer 
primary health-care systems in an integrated way, rather 
than foster their further fragmentation, this approach 
will provide a basis to fully exploit the strengths of 
primary health care, many of which are still unrealised.
The primary health-care system spans a crucial interface 
between ﬁ rst-line clinical care, which is generally provided 
by mid-level health workers, and community-based 
prevention and promotion, involving a range of 
community workers, local organisations, and households. 
It is this level of care that holds much promise for health 
development in resource-poor settings. Yet for much of 
sub-Saharan Africa, health-system performance has fallen 
far below expectations.37 How then could added complexity, 
in the form of integrated chronic care, invigorate primary 
health care?
Arguably, the complexity of establishing eﬀ ective 
primary health-care systems has never been properly 
acknowledged. As a result, the sustained skill and 
creativity of national planners and the research 
community have been applied elsewhere. Further, 
individual recognition and promotion within the public 
service is generally associated with movement away from 
local and district levels and into provincial or national 
oﬃ  ces. These deﬁ cits, and not only international funding 
for single-purpose initiatives, have contributed to the 
proliferation of vertical programmes that have divided 
the integrated platform which is needed for eﬀ ective 
community-level care. A clearer, more realistic perspective 
on the challenges presented by primary health care, and 
the policy, planning, and programming expertise 
required, could revitalise the research and development 
eﬀ orts that are needed to bring success.
Potential for widespread decentralised provision of 
HAART is high, and the evidence and experience now 
exist to support it.29,38,39 Certainly this is the case in South 
Africa, where growing numbers of community health 
centres are belatedly being accredited to deliver 
comprehensive care, the government has increased 
available resources, and political support is more overt. 
The requirements for eﬀ ective, decentralised provision 
Panel: Management of chronic non-communicable disease 
in Agincourt
As in much of southern Africa, subdistrict services are based 
on a network of clinics that are staﬀ ed by primary-care 
nurses; support is inadequate, drug supply irregular, and 
medical supervision sporadic. Recent work examining the 
management of stroke, blood pressure, and tuberculosis 
described a major gap in the capacity to manage chronic 
illness. 
Of 103 conﬁ rmed stroke survivors, only one was taking 
aspirin; of 85 with evidence of hypertension, eight were 
being treated but only one was adequately controlled. Thus 
no system of secondary prevention seemed to be in 
operation.24 
In a survey of adults aged 35 years and older, 43% showed 
some degree of hypertension; 24% of these patients had used 
drug treatment in the past week, half of whom had a blood 
pressure reading less than 140/90 mm Hg, indicating the 
limits of primary prevention.13
Although hospital management of pulmonary tuberculosis 
was eﬀ ective, most patients with active disease that was 
missed, or those who died before receiving treatment, had 
presented to a local clinic.33 Some two-thirds of patients, 
already seen at a clinic, presented to hospital after 
self-referral or at the insistence of family, friends, or 
employers, leading to delays in start of treatment.34 
Care-seeking was pluralistic, involving allopathic, traditional, 
and faith-based healers; notably, however, most ﬁ rst visits 
were to local clinics, underlining their pivotal role.34,35
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of HAART, and those needed for competent local 
management of chronic non-communicable diseases, 
are closely aligned (table 3). Thus the eﬀ ort, services, and 
resources which are directed at people and communities 
infected and aﬀ ected by HIV/AIDS can be harnessed to 
fundamentally strengthen a crucial delivery platform for 
the range of chronic disorders. Doing so would greatly 
enhance the technical eﬃ  ciency of key elements of the 
general primary health-care system, and realise the 
diagonal—“a strategy in which explicit intervention 
priorities are used to drive the necessary improvements 
into the health system”.40
WHO has given serious attention to formulating and 
testing frameworks for chronic care systems,32,41,42 and to 
the skill-set that is required of multipurpose health 
workers to support long-term patient-centred care.31 WHO 
staﬀ  repeatedly note that an incremental approach is 
unlikely to succeed; rather, that a concerted shift, 
amounting to the redesign of delivery systems, is needed 
to achieve meaningful change. The challenge in adapting 
normative frameworks to underperforming systems in 
sub-Saharan Africa should not be underestimated. The 
gains from integration of care for chronic infectious and 
non-communicable diseases—in terms of service 
eﬃ  ciency, quality and acceptability to users, and the eﬀ ects 
on health status—will need to be shown. Thus a serious 
research and development agenda is needed that addresses 
which aspects of service integration are likely to be 
eﬀ ective, how best to introduce them, and ensuring that 
assessment is based on rigorous study designs (including 
controlled trials of such complex interventions, the costs 
incurred, and probable sustainability). Results from earlier 
eﬀ orts to integrate reproductive health services are mixed, 
although recent evidence on the beneﬁ ts of integrating 
primary child-care services is encouraging.43
Thorough understanding of the dynamics of health 
transition is important to achieve a serious appraisal of 
primary health-care systems in southern Africa and 
further aﬁ eld. We conclude that a new approach to 
primary health-care systems is needed, with management 
of chronic disorders a key element. Central to health-
system performance are leadership and staﬀ  competence. 
Service leaders at primary-care level will need to develop 
innovative responses to the demanding realities that they 
face. A range of less-practised skills—addressing personal 
behaviour and the inﬂ uence of peer-groups, partnerships 
with community groups, service monitoring and 
assessment, and alliance formation across health and 
development sectors—will need emphasis to ensure that 
adequate levels of service coverage and treatment 
adherence result. Given high levels of labour migration 
in the region, and the many ill migrants who return to 
their rural homes for social support and medical care,12 
continuity of care will depend on eﬀ ective communication 
of treatment histories between urban clinics and rural 
services. Chronic illness can impose heavy social and 
HAART Chronic NCD care
Primary care facility
Clinic management Continuity and coordination As for HAART
Quality assurance Continuity and coordination As for HAART
Clinic infrastructure Specialised space within general service for counselling, treatment 
literacy, data capture
As for HAART
Support services Laboratory; drug supply As for HAART
Health worker skills and attitudes: training and 
mentoring; promote morale and motivation
Extend and diversify health-care team: eg, clinical assistants, lay 
health workers and counsellors, pharmacy and laboratory 
assistants, data typist
As for HAART
Patient-centred care and support Decision support; self-management support; patient support 
groups
As for HAART
Screening Voluntary counselling and testing; tuberculosis Blood pressure, blood glucose, lipids, etc
Standard treatment protocols For HAART, PMTCT, opportunistic infections, tuberculosis For diabetes, blood pressure, epilepsy, cardiac failure
Interface: facility and community
Patient adherence: counselling; peer education Promote patient adherence to reduce risk of drug resistance Encourage treatment compliance to improve individual outcomes
Prevention and promotion programmes: community 
awareness/mobilisation; involvement of other sectors
Address issues of stigma Intervene across disease continuum
Referral systems: community–clinic–hospital Transport; communication As for HAART
Community
Community-based care and support Community health workers support home-based care; 
complementary providers: traditional and faith healers; support 
groups: church-based, revolving funds, income-generating
As for HAART
Primary health-care system
Monitoring and evaluation Treatment cohorts; programme coverage and eﬀ ectiveness As for HAART
HAART=highly active antiretroviral therapy. NCD=non-communicable disease. PMTCT=prevention of mother-to-child transmission. 
Table 3: Key elements of primary health care in practice—integration of HAART and chronic non-communicable disease care
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monetary costs on poor households.44 The imperative, 
therefore, to develop quality primary health-care systems, 
which are able to address eﬀ ectively the rapidly expanding 
burden of chronic illness, could not be greater. 
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